CNET on MSN6mon
Abbott Warns Small Number of FreeStyle Libre 3 Sensors May Give Inaccurate Readings
Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...
GlobalData on MSN4mon
FDA hits Abbott FreeStyle Libre 3 recall with Class I tag
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...
Medscape2y
FreeStyle Libre 3: 'Almost Like Wearing Nothing'
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
drugdeliverybusiness12d
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
pharmaphorum3d
Real-time Abbott glucose monitor available to NHS after UK launch
Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...